Sarcopenia With Limited Mobility

An International Consensus

John E. Morley, Angela Marie Abbatecola, Josep M. Argiles, Vickie Baracos, Juergen Bauer, Shalender Bhasin, Tommy Cederholm, Andrew J. Stewart Coats, Steven R. Cummings, William J. Evans, Kenneth Fearon, Luigi Ferrucci, Roger A. Fielding, Jack M. Guralnik, Tamara B. Harris, Akio Inui, Kamyar Kalantar-Zadeh, Bridget Anne Kirwan, Giovanni Mantovani, Maurizio Muscaritoli & 11 others Anne B. Newman, Filippo Rossi-Fanelli, Giuseppe M C Rosano, Ronenn Roubenoff, Morris Schambelan, Gerald H. Sokol, Thomas W. Storer, Bruno Vellas, Stephan von Haehling, Shing Shing Yeh, Stefan D. Anker

Research output: Contribution to journalArticle

Abstract

A consensus conference convened by the Society of Sarcopenia, Cachexia and Wasting Disorders has concluded that " Sarcopenia, ie, reduced muscle mass, with limited mobility" should be considered an important clinical entity and that most older persons should be screened for this condition. " Sarcopenia with limited mobility" is defined as a person with muscle loss whose walking speed is equal to or less than 1 m/s or who walks less than 400 m during a 6-minute walk, and who has a lean appendicular mass corrected for height squared of 2 standard deviations or more below the mean of healthy persons between 20 and 30 years of age of the same ethnic group. The limitation in mobility should not clearly be a result of otherwise defined specific diseases of muscle, peripheral vascular disease with intermittent claudication, central and peripheral nervous system disorders, or cachexia. Clinically significant interventions are defined as an increase in the 6-minute walk of at least 50 meters or an increase of walking speed of at least 0.1 m/s.

Original languageEnglish (US)
Pages (from-to)403-409
Number of pages7
JournalJournal of the American Medical Directors Association
Volume12
Issue number6
DOIs
StatePublished - Jul 2011
Externally publishedYes

Fingerprint

Sarcopenia
Cachexia
Muscles
Mobility Limitation
Intermittent Claudication
Peripheral Vascular Diseases
Central Nervous System Diseases
Peripheral Nervous System Diseases
Ethnic Groups
Walking Speed

ASJC Scopus subject areas

  • Medicine(all)
  • Nursing(all)
  • Health Policy

Cite this

Morley, J. E., Abbatecola, A. M., Argiles, J. M., Baracos, V., Bauer, J., Bhasin, S., ... Anker, S. D. (2011). Sarcopenia With Limited Mobility: An International Consensus. Journal of the American Medical Directors Association, 12(6), 403-409. https://doi.org/10.1016/j.jamda.2011.04.014

Sarcopenia With Limited Mobility : An International Consensus. / Morley, John E.; Abbatecola, Angela Marie; Argiles, Josep M.; Baracos, Vickie; Bauer, Juergen; Bhasin, Shalender; Cederholm, Tommy; Stewart Coats, Andrew J.; Cummings, Steven R.; Evans, William J.; Fearon, Kenneth; Ferrucci, Luigi; Fielding, Roger A.; Guralnik, Jack M.; Harris, Tamara B.; Inui, Akio; Kalantar-Zadeh, Kamyar; Kirwan, Bridget Anne; Mantovani, Giovanni; Muscaritoli, Maurizio; Newman, Anne B.; Rossi-Fanelli, Filippo; Rosano, Giuseppe M C; Roubenoff, Ronenn; Schambelan, Morris; Sokol, Gerald H.; Storer, Thomas W.; Vellas, Bruno; von Haehling, Stephan; Yeh, Shing Shing; Anker, Stefan D.

In: Journal of the American Medical Directors Association, Vol. 12, No. 6, 07.2011, p. 403-409.

Research output: Contribution to journalArticle

Morley, JE, Abbatecola, AM, Argiles, JM, Baracos, V, Bauer, J, Bhasin, S, Cederholm, T, Stewart Coats, AJ, Cummings, SR, Evans, WJ, Fearon, K, Ferrucci, L, Fielding, RA, Guralnik, JM, Harris, TB, Inui, A, Kalantar-Zadeh, K, Kirwan, BA, Mantovani, G, Muscaritoli, M, Newman, AB, Rossi-Fanelli, F, Rosano, GMC, Roubenoff, R, Schambelan, M, Sokol, GH, Storer, TW, Vellas, B, von Haehling, S, Yeh, SS & Anker, SD 2011, 'Sarcopenia With Limited Mobility: An International Consensus', Journal of the American Medical Directors Association, vol. 12, no. 6, pp. 403-409. https://doi.org/10.1016/j.jamda.2011.04.014
Morley, John E. ; Abbatecola, Angela Marie ; Argiles, Josep M. ; Baracos, Vickie ; Bauer, Juergen ; Bhasin, Shalender ; Cederholm, Tommy ; Stewart Coats, Andrew J. ; Cummings, Steven R. ; Evans, William J. ; Fearon, Kenneth ; Ferrucci, Luigi ; Fielding, Roger A. ; Guralnik, Jack M. ; Harris, Tamara B. ; Inui, Akio ; Kalantar-Zadeh, Kamyar ; Kirwan, Bridget Anne ; Mantovani, Giovanni ; Muscaritoli, Maurizio ; Newman, Anne B. ; Rossi-Fanelli, Filippo ; Rosano, Giuseppe M C ; Roubenoff, Ronenn ; Schambelan, Morris ; Sokol, Gerald H. ; Storer, Thomas W. ; Vellas, Bruno ; von Haehling, Stephan ; Yeh, Shing Shing ; Anker, Stefan D. / Sarcopenia With Limited Mobility : An International Consensus. In: Journal of the American Medical Directors Association. 2011 ; Vol. 12, No. 6. pp. 403-409.
@article{e572bbedad9744f28471cec2a6e7f456,
title = "Sarcopenia With Limited Mobility: An International Consensus",
abstract = "A consensus conference convened by the Society of Sarcopenia, Cachexia and Wasting Disorders has concluded that {"} Sarcopenia, ie, reduced muscle mass, with limited mobility{"} should be considered an important clinical entity and that most older persons should be screened for this condition. {"} Sarcopenia with limited mobility{"} is defined as a person with muscle loss whose walking speed is equal to or less than 1 m/s or who walks less than 400 m during a 6-minute walk, and who has a lean appendicular mass corrected for height squared of 2 standard deviations or more below the mean of healthy persons between 20 and 30 years of age of the same ethnic group. The limitation in mobility should not clearly be a result of otherwise defined specific diseases of muscle, peripheral vascular disease with intermittent claudication, central and peripheral nervous system disorders, or cachexia. Clinically significant interventions are defined as an increase in the 6-minute walk of at least 50 meters or an increase of walking speed of at least 0.1 m/s.",
author = "Morley, {John E.} and Abbatecola, {Angela Marie} and Argiles, {Josep M.} and Vickie Baracos and Juergen Bauer and Shalender Bhasin and Tommy Cederholm and {Stewart Coats}, {Andrew J.} and Cummings, {Steven R.} and Evans, {William J.} and Kenneth Fearon and Luigi Ferrucci and Fielding, {Roger A.} and Guralnik, {Jack M.} and Harris, {Tamara B.} and Akio Inui and Kamyar Kalantar-Zadeh and Kirwan, {Bridget Anne} and Giovanni Mantovani and Maurizio Muscaritoli and Newman, {Anne B.} and Filippo Rossi-Fanelli and Rosano, {Giuseppe M C} and Ronenn Roubenoff and Morris Schambelan and Sokol, {Gerald H.} and Storer, {Thomas W.} and Bruno Vellas and {von Haehling}, Stephan and Yeh, {Shing Shing} and Anker, {Stefan D.}",
year = "2011",
month = "7",
doi = "10.1016/j.jamda.2011.04.014",
language = "English (US)",
volume = "12",
pages = "403--409",
journal = "Journal of the American Medical Directors Association",
issn = "1525-8610",
publisher = "Elsevier Inc.",
number = "6",

}

TY - JOUR

T1 - Sarcopenia With Limited Mobility

T2 - An International Consensus

AU - Morley, John E.

AU - Abbatecola, Angela Marie

AU - Argiles, Josep M.

AU - Baracos, Vickie

AU - Bauer, Juergen

AU - Bhasin, Shalender

AU - Cederholm, Tommy

AU - Stewart Coats, Andrew J.

AU - Cummings, Steven R.

AU - Evans, William J.

AU - Fearon, Kenneth

AU - Ferrucci, Luigi

AU - Fielding, Roger A.

AU - Guralnik, Jack M.

AU - Harris, Tamara B.

AU - Inui, Akio

AU - Kalantar-Zadeh, Kamyar

AU - Kirwan, Bridget Anne

AU - Mantovani, Giovanni

AU - Muscaritoli, Maurizio

AU - Newman, Anne B.

AU - Rossi-Fanelli, Filippo

AU - Rosano, Giuseppe M C

AU - Roubenoff, Ronenn

AU - Schambelan, Morris

AU - Sokol, Gerald H.

AU - Storer, Thomas W.

AU - Vellas, Bruno

AU - von Haehling, Stephan

AU - Yeh, Shing Shing

AU - Anker, Stefan D.

PY - 2011/7

Y1 - 2011/7

N2 - A consensus conference convened by the Society of Sarcopenia, Cachexia and Wasting Disorders has concluded that " Sarcopenia, ie, reduced muscle mass, with limited mobility" should be considered an important clinical entity and that most older persons should be screened for this condition. " Sarcopenia with limited mobility" is defined as a person with muscle loss whose walking speed is equal to or less than 1 m/s or who walks less than 400 m during a 6-minute walk, and who has a lean appendicular mass corrected for height squared of 2 standard deviations or more below the mean of healthy persons between 20 and 30 years of age of the same ethnic group. The limitation in mobility should not clearly be a result of otherwise defined specific diseases of muscle, peripheral vascular disease with intermittent claudication, central and peripheral nervous system disorders, or cachexia. Clinically significant interventions are defined as an increase in the 6-minute walk of at least 50 meters or an increase of walking speed of at least 0.1 m/s.

AB - A consensus conference convened by the Society of Sarcopenia, Cachexia and Wasting Disorders has concluded that " Sarcopenia, ie, reduced muscle mass, with limited mobility" should be considered an important clinical entity and that most older persons should be screened for this condition. " Sarcopenia with limited mobility" is defined as a person with muscle loss whose walking speed is equal to or less than 1 m/s or who walks less than 400 m during a 6-minute walk, and who has a lean appendicular mass corrected for height squared of 2 standard deviations or more below the mean of healthy persons between 20 and 30 years of age of the same ethnic group. The limitation in mobility should not clearly be a result of otherwise defined specific diseases of muscle, peripheral vascular disease with intermittent claudication, central and peripheral nervous system disorders, or cachexia. Clinically significant interventions are defined as an increase in the 6-minute walk of at least 50 meters or an increase of walking speed of at least 0.1 m/s.

UR - http://www.scopus.com/inward/record.url?scp=79959617857&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79959617857&partnerID=8YFLogxK

U2 - 10.1016/j.jamda.2011.04.014

DO - 10.1016/j.jamda.2011.04.014

M3 - Article

VL - 12

SP - 403

EP - 409

JO - Journal of the American Medical Directors Association

JF - Journal of the American Medical Directors Association

SN - 1525-8610

IS - 6

ER -